Through a structured, interactive approach designed to facilitate collaborative discussion, the MS roundtable sought to identify areas of common ground between healthcare providers (HCPs) and payers in making clinically appropriate, value-based patient management decisions. HCPs and payers represented on the panel discussed their responsibilities, goals, and challenges in an open forum that encouraged the candid exchange of ideas.
Achieving glucose, blood pressure, and lipid targets improving among diabetic patients, but there’s still long way to go
Management of blood glucose, blood pressure, and lipids in patients with diabetes has improved markedly over the past decade, but achievement of goal levels is still suboptimal.
Only about half of patients achieved the American Diabetes Association (ADA) targets for each of these measures in the period from 2007 to 2010, and fewer than 1 in 5 achieved all 3 of the goals, according to data from the National Health and Nutrition Examination Surveys (NHANES).
San Diego, CA—During the 2011 Scientific Sessions of the American Diabetes Association (ADA), American Health & Drug Benefits interviewed Robert Henry, MD, ADA President, Medicine & Science, and Chief, Endocrinology Division, San Diego Veterans Affairs Healthcare System, and Professor of Medicine in Residence at the University of California, San Diego.
San Diego, CA—Adding saxagliptin to metformin instead of increasing the dose of metformin significantly improves levels of hemoglobin (Hb)A1c, fasting plasma glucose, and postprandial glucose in patients with type 2 diabetes who demonstrate inadequate glycemic control despite receiving a stable dose of metformin, according to the results of a randomized, open-label study presentedat the 71st Scientific Sessions of the American Diabetes Association.
San Diego, CA—Results from a pair of phase 3 clinical trials show that injection of an antivascular endothelial growth factor antibody fragment significantly and rapidly improves vision in patients with diabetes and macular degeneration. The improvements are sustained to 2 years, said David S. Boyer, MD, an ophthalmologist at Retina-Vitreous Associates, Beverly Hills, CA, during his presentation at the 2011 Scientific Sessions of the American Diabetes Association.
San Diego, CA—An initial evaluation of a fully automated artificial pancreas demonstrated that the system can safely regulate glycemia in patients with type 1 diabetes, even after a meal challenge without previous meal information, said Howard Zisser, MD, Director of Clinical Research and Technology, Sansum Diabetes Research Institute, and Adjunct Professor, Department of Chemical Engineering, University of California, Santa Barbara, during the 2011 Scientific Sessions of the American Diabetes Association.
On May 18, 2016, the US Food and Drug Administration (FDA) approved atezolizumab (Tecentriq; Genentech) for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or after platinum-containing chemotherapy, or who have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.
San Diego, CA—Blood glucose testing constitutes more than 20% of US pharmacy costs in patients taking insulin, investigators from the IMS Consulting Group, Alexandria, VA, found in a study presented at the 2011 Scientific Sessions of the American Diabetes Association.
“New insulin regimens with simpler, user-friendly dosing options and simpler titration are warranted in order to enable relevant cost-savings,” the researchers stated.
Work productivity and quality of life are significantly worse in workers aged ≥65 years with chronic obstructive pulmonary disease (COPD) compared with those without COPD, according to survey data presented at Chest 2010.
Researchers examined the health outcomes of 3358 older employees (aged ≥65 years) using the US 2009 National Health and Wellness Survey, an online cross-sectional survey. Of these employees, 297 self-reported a diagnosis of COPD and 3061 did not.
Page 1 of 10
Results 1 - 10 of 98
Results 1 - 10 of 98